UnknownNot Applicable

Metabolic Disorders and Vertigo

Russia100 participantsStarted 2019-12-10

Plain-language summary

The purpose of investigation is to assess the levels of metabolic factors (hydroxyvitamin D, homocysteine) between patients with vestibular dysfunction of peripheral origin (BPPV) and central origin (vestibular migraine). Also we will analyse another factors (such as anxiety and depression) and optimize therapeuthical approach accordingly with the data.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Written informed consent of participation in the study; * Age:over 18 years old * complaints of dizziness and insteadiness Exclusion Criteria: * Severe cognitive impairment (dementia) * Severe depression * Syncopal paroxysms * Epileptic seizures * Orthostatic hypotension * Severe arrhythmia, unstable angina pectoris, acute myocardial infarction * Pregnancy 8. Alcoholism, substance abuse and drug addiction * Organic liver and kidney diseases with the development of functional disorders. * Anemia (hemoglobin \<10.5 g / dl for women and \<11.5 g / dl for men) * Active oncological process * Demyelinating and neurodegenerative diseases.

What they're measuring

vitamin D deficiency/insufficiency reveal

Timeframe: Through 1-6 months of diagnosis established.

hyperhomocysteinaemia reveal

Timeframe: Through 1-6 months of diagnosis established.

Trial details

NCT IDNCT04935970

SponsorI.M. Sechenov First Moscow State Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-30

Contact for this trial

Ludmila Antonenko, professor

89265774431 luda6917@yandex.ru

View on ClinicalTrials.gov More Benign Paroxysmal Positional Vertigo (BPPV) trials